ES2042667T3 - Procedimiento para la fabricacion de un preparado de transferina, biologicamente activo, seguro contra virus, de gran pureza. - Google Patents

Procedimiento para la fabricacion de un preparado de transferina, biologicamente activo, seguro contra virus, de gran pureza.

Info

Publication number
ES2042667T3
ES2042667T3 ES88114592T ES88114592T ES2042667T3 ES 2042667 T3 ES2042667 T3 ES 2042667T3 ES 88114592 T ES88114592 T ES 88114592T ES 88114592 T ES88114592 T ES 88114592T ES 2042667 T3 ES2042667 T3 ES 2042667T3
Authority
ES
Spain
Prior art keywords
biologically active
procedure
manufacture
great purity
against viruses
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES88114592T
Other languages
English (en)
Spanish (es)
Inventor
Ulf Dr Bethke
Norbert Dr Kothe
Dieter Dr Rudnick
Wolfgang Dr Moller
Michael Dr Kloft
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Biotest Pharma GmbH
Original Assignee
Biotest Pharma GmbH
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Biotest Pharma GmbH filed Critical Biotest Pharma GmbH
Application granted granted Critical
Publication of ES2042667T3 publication Critical patent/ES2042667T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/18—Growth factors; Growth regulators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2/00—Methods or apparatus for disinfecting or sterilising materials or objects other than foodstuffs or contact lenses; Accessories therefor
    • A61L2/16—Methods or apparatus for disinfecting or sterilising materials or objects other than foodstuffs or contact lenses; Accessories therefor using chemical substances
    • A61L2/18—Liquid substances or solutions comprising solids or dissolved gases
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2/00—Methods or apparatus for disinfecting or sterilising materials or objects other than foodstuffs or contact lenses; Accessories therefor
    • A61L2/0005—Methods or apparatus for disinfecting or sterilising materials or objects other than foodstuffs or contact lenses; Accessories therefor for pharmaceuticals, biologicals or living parts
    • A61L2/0082—Methods or apparatus for disinfecting or sterilising materials or objects other than foodstuffs or contact lenses; Accessories therefor for pharmaceuticals, biologicals or living parts using chemical substances
    • A61L2/0088—Liquid substances
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/08—Solutions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2/00—Methods or apparatus for disinfecting or sterilising materials or objects other than foodstuffs or contact lenses; Accessories therefor
    • A61L2/02—Methods or apparatus for disinfecting or sterilising materials or objects other than foodstuffs or contact lenses; Accessories therefor using physical phenomena
    • A61L2/08—Radiation
    • A61L2/10—Ultraviolet radiation
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/79—Transferrins, e.g. lactoferrins, ovotransferrins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61L2103/05—

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Organic Chemistry (AREA)
  • Molecular Biology (AREA)
  • Zoology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Genetics & Genomics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Toxicology (AREA)
  • Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Immunology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
ES88114592T 1987-10-01 1988-09-07 Procedimiento para la fabricacion de un preparado de transferina, biologicamente activo, seguro contra virus, de gran pureza. Expired - Lifetime ES2042667T3 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE3733181A DE3733181C1 (de) 1987-10-01 1987-10-01 Verfahren zur Herstellung eines hochreinen,virussicheren,biologisch aktiven Transferrinpraeparates

Publications (1)

Publication Number Publication Date
ES2042667T3 true ES2042667T3 (es) 1993-12-16

Family

ID=6337381

Family Applications (1)

Application Number Title Priority Date Filing Date
ES88114592T Expired - Lifetime ES2042667T3 (es) 1987-10-01 1988-09-07 Procedimiento para la fabricacion de un preparado de transferina, biologicamente activo, seguro contra virus, de gran pureza.

Country Status (8)

Country Link
US (1) US5041537A (enExample)
EP (1) EP0309787B1 (enExample)
JP (1) JPH01106828A (enExample)
KR (1) KR890006251A (enExample)
AT (1) ATE77242T1 (enExample)
DE (2) DE3733181C1 (enExample)
ES (1) ES2042667T3 (enExample)
GR (1) GR3005037T3 (enExample)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4891221A (en) * 1988-11-23 1990-01-02 Edward Shanborm Whole blood antiviral process and composition
DE4039721A1 (de) * 1990-12-13 1992-06-17 Behringwerke Ag Verfahren zur herstellung eines pasteurisierten und eisenfreien human-transferrins und seine verwendung
US5986067A (en) * 1991-02-08 1999-11-16 The University Of Vermont And State Agricultural College Recombinant transferrins, transferrin half-molecules and mutants thereof
CA2103583C (en) * 1991-02-08 2009-10-13 Walter D. Funk Recombinant transferrins, transferrin half-molecules and mutants thereof
US6825037B1 (en) 1991-02-08 2004-11-30 University Of Vermont Recombinant transferrins, transferrin half-molecules and mutants thereof
US5744586A (en) * 1996-06-26 1998-04-28 Alpha Therapeutic Corporation Manufacturing process for the production of purified transferrin
US6251860B1 (en) * 1998-07-07 2001-06-26 Suomen Punainen Risti Veripalvelu Pharmaceutical preparations
US6326473B1 (en) 1998-12-30 2001-12-04 Suomen Punainen Risti Veripalvelu Pharmaceutical preparations
US20030211137A1 (en) * 2001-02-21 2003-11-13 David Sierra Foam-forming wound dressing
DE10215315A1 (de) * 2002-04-05 2003-11-20 Aventis Behring Gmbh Intellect Human-Transferrin zur Behandlung der Anaemia of Chronic Disease (ACD) und des funktionellen Eisenmangels
WO2003086272A2 (en) * 2002-04-16 2003-10-23 Kamada Ltd. Ultrapure transferrin for pharmaceutical compositions
GB0711424D0 (en) * 2007-06-13 2007-07-25 Novozymes Delta Ltd Recombinant transferrin mutants
EP2617733A1 (en) 2009-02-06 2013-07-24 Novozymes Biopharma DK A/S Purification process
JP6200805B2 (ja) * 2010-05-03 2017-09-20 グラクソスミスクライン バイオロジカルズ ソシエテ アノニム 新規な方法
US9492509B2 (en) 2011-11-11 2016-11-15 Fundaciö Institut D'investigació En Ciències De La Salut Germans Trias I Pujol Apotransferrin for the treatment of brain stroke
US9534029B2 (en) 2012-10-03 2017-01-03 Csl Behring Ag Method of purifying proteins
WO2022271955A1 (en) 2021-06-23 2022-12-29 Musc Foundation For Research Development Novel targeted shrna nanoparticles for cancer therapy

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT1048150B (it) * 1973-10-31 1980-11-20 O T I Officina Terapeutica Ita Metodo per l isolamento delle transferine da materiali biologici
DE3033932C2 (de) * 1980-09-10 1984-05-24 Biotest-Serum-Institut Gmbh, 6000 Frankfurt Verfahren zur Kaltsterilisation von Blutgerinnungsfaktor VIII enthaltenden Präparaten
US4481189A (en) * 1982-04-14 1984-11-06 New York Blood Center Inc. Process for preparing sterilized plasma and plasma derivatives
US4540573A (en) * 1983-07-14 1985-09-10 New York Blood Center, Inc. Undenatured virus-free biologically active protein derivatives
JPS6054287B2 (ja) * 1983-10-19 1985-11-29 株式会社ミドリ十字 血漿蛋白の加熱処理方法
US4841026A (en) * 1987-01-27 1989-06-20 Miles Laboratories, Inc. Virally inactivated, non-toxic, human transferrin preparation

Also Published As

Publication number Publication date
JPH01106828A (ja) 1989-04-24
EP0309787A3 (en) 1990-02-28
DE3733181C1 (de) 1989-01-19
DE3872137D1 (de) 1992-07-23
US5041537A (en) 1991-08-20
ATE77242T1 (de) 1992-07-15
GR3005037T3 (enExample) 1993-05-24
EP0309787B1 (de) 1992-06-17
KR890006251A (ko) 1989-06-12
EP0309787A2 (de) 1989-04-05

Similar Documents

Publication Publication Date Title
ES2042667T3 (es) Procedimiento para la fabricacion de un preparado de transferina, biologicamente activo, seguro contra virus, de gran pureza.
US6861001B2 (en) Methods for removal, purification, and concentration of viruses, and methods of therapy based thereupon
US6270672B1 (en) Devices and methods for removing pathogens from biological fluids
DK0775150T3 (da) Fremgangsmåde til reduktion eller fjernelse af endotoksiner
KR860008276A (ko) 단백질이 생성된 배양기로 부터 그것을 추출, 정제하는 방법
US10253299B2 (en) Sulfated cellulose hydrate membrane, method for producing same, and use of the membrane as an adsorption membrane for a virus purification process
CN112391383B (zh) 一种质粒dna的产业化纯化方法及质粒dna
DE69022983D1 (de) Behandlung von verunreinigten flüssigen strömen aus ethylenoxid/glycol-herstellungsprozessen mit semipermeablen membranen.
EP0669342B1 (de) Verfahren zur Isolierung und Reinigung Vitamin K-abhängiger Proteine
CN114181300A (zh) 一种高纯度单克隆抗体的制备方法
US6867285B2 (en) Virus-free plasma protein compositions treated with porous membrane and process for producing the same
CN112898408B (zh) 一种蛋清中卵白蛋白的分离方法与装置
FI116569B (fi) Menetelmä virusinaktivoidun, tekijä-VIII-pitoisen fraktion valmistamiseksi kromatografisilla menetelmillä
AU2014326706A1 (en) Method for the clarification of high density crude cell culture harvest
US5173415A (en) Process for removal of viruses from solutions of physiologically active substances
JP2002505674A (ja) 生物材料中のウイルスおよび分子病原体を除去する方法
CN109134622A (zh) 口蹄疫病毒抗原的多步连续集成纯化方法
NAKANO et al. The effect of charges on permeabilities of drugs through collagen membranes
RU2120804C1 (ru) Способ приготовления вакцины против клещевого или японского энцефалита из вирусной суспензии
RU2062617C1 (ru) Способ получения антитоксической сыворотки
JPH01141593A (ja) ウロキナーゼの回収方法及びそれにより得られるウロキナーゼ含有画分
Cooke et al. An antiviral substance from Penicillium cyaneo-fulvum biourge: I. Production and partial purification
JP2012112930A (ja) 高分子量物質の精製方法
KR930008097B1 (ko) 콜로니 형성 자극 인자의 정제방법
Finkelstein Thromboplastic activity of placenta extract

Legal Events

Date Code Title Description
FG2A Definitive protection

Ref document number: 309787

Country of ref document: ES